UNQUOTE

GERMANY - Creathor backs EUR 4m Cevec investment

  • Mareen
  • LinkedIn  
  • Google plus  

Creathor Venture Fonds and NRW Bank have co-led a EUR 4m investment in biotechnology company Cevec Pharmaceuticals, alongside a syndicate of private and institutional investors, including the venture capital branch of Sparkasse KoelnBonn and KfW bank's ERP Startfonds.

Cologne-headquartered Cevec, which was founded in 2004, specialises in developing and producing therapeutic proteins and monoclonal antibodies with human glycosylation patterns, which can be used to manufacture complex biopharmaceutical molecules. The company is licensing out its human cell-based expression platform as well as the biological product candidates through partnerships with pharmaceutical and biotech companies.

  • LinkedIn  
  • Google plus  

More on Expansion

Latest News